Lobe Sciences Appoints Yong Yao as CFO for Strategic Initiatives

Lobe Sciences Ltd. has appointed Yong Yao as Chief Financial Officer and Executive Vice President, effective June 1, 2025. Mr. Yao, with over 25 years of experience in finance and biotech, is set to lead the company's financial strategy in its growth phase.

Previously, Yao held executive roles at Mountain Valley MD and financial institutions like Morgan Stanley and Scotiabank. His expertise in financial strategy and biotechnology will support Lobe’s regulatory compliance, capital market readiness, and operational expansion.

This appointment signifies a strategic shift for Lobe as it enhances its financial oversight and disclosure standards. Dr. Frederick D. Sancilio, CEO of Lobe, expressed excitement for the valuable depth Yao brings to the finance function.